Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Impaired”

847 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 847 results

Early research (Phase 1)Study completedNCT04476407
What this trial is testing

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

Who this might be right for
Complicated Urinary Tract Infection; Cuti
Sihuan Pharmaceutical Holdings Group Ltd. 18
Early research (Phase 1)Study completedNCT01424176
What this trial is testing

Dexpramipexole Renal PK Study

Who this might be right for
Amyotrophic Lateral SclerosisRenal Insufficiency
Knopp Biosciences 36
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Not applicableEnded earlyNCT01392196
What this trial is testing

Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial

Who this might be right for
Heart Failure
Medtronic Vascular 39
Early research (Phase 1)Study completedNCT06559527
What this trial is testing

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

Who this might be right for
Diabetes Mellitus, Type 2ObesityOverweight
Novo Nordisk A/S 42
Early research (Phase 1)Study completedNCT02894905
What this trial is testing

Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

Who this might be right for
Renal Insufficiency
Janssen Research & Development, LLC 24
Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Testing effectiveness (Phase 2)Ended earlyNCT00790842
What this trial is testing

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
PrECOG, LLC. 63
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT06527677
What this trial is testing

Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

Who this might be right for
Renal Impairment
Antabio 41
Not applicableLooking for participantsNCT04722939
What this trial is testing

Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury

Who this might be right for
DeliriumAcute Kidney InjuryCritical Illness+3 more
Dr. Gordon Boyd 104
Not applicableUnknownNCT03622957
What this trial is testing

Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2AlbuminuriaCardiovascular Risk Factor
University of Pisa 200
Early research (Phase 1)Study completedNCT05841277
What this trial is testing

LY3819469 in Participants With Impaired and Normal Renal Function

Who this might be right for
Renal InsufficiencyHealthy
Eli Lilly and Company 26
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Early research (Phase 1)UnknownNCT02840812
What this trial is testing

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

Who this might be right for
Kidney Dysfunction
Zhejiang Medicine Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT05323136
What this trial is testing

Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics

Who this might be right for
ACS - Acute Coronary Syndrome
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 2
Early research (Phase 1)Study completedNCT04364464
What this trial is testing

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Clinical Pharmacology
Bayer 40
Early research (Phase 1)Study completedNCT04699032
What this trial is testing

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

Who this might be right for
Chronic Kidney Disease
VectivBio AG 16
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Next Page